Skip to main content
Log in

The oxidant–antioxidant balance in systemic sclerosis cases with interstitial lung involvement

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

We aimed to assess the plasma oxidant and antioxidant levels in systemic sclerosis (SS) patients with interstitial lung involvement. Twenty-seven female SS patients and 17 healthy female volunteers were included in the study. Plasma levels of oxidants and antioxidants levels were studied of two groups. The median oxidant and antioxidant levels in study and control groups were, MDA 5.2 ± 0.4/3.7 ± 0.5 nmol/ml (P < 0.001), NO 45.4 ± 3.7/34.2 ± 2.9 nmol/l (P < 0.001), SOD 25.6 ± 2.3/24.6 ± 2.0 U/ml (P > 0.05), catalase 99.9 ± 9.9/140.0 ± 10.0 U/ml (P < 0.001), vitamin E 20.5 ± 1.3/22.6 ± 2.0%mg (P < 0.001), vitamin C 70.6 ± 8.7/83.5 ± 7.3 mg/dl (P < 0.001), respectively. There was also no correlation between plasma levels of oxidants–antioxidants levels and disease duration, duration of pulmonary signs, pulmonary function test values, HRCT scores in SS patients (P > 0.05). In our study, the oxidant burden in SS patients with interstitial lung involvement was found to be increased; however no correlation was detected between the severity of lung involvement and oxidant–antioxidant levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Freemer MM, King TE Jr (2003) Connective tissue diseases. In: Schwarz MI, King TE Jr (eds) Interstitial lung disease. Decker Inc, London BC, pp 535–598

    Google Scholar 

  2. Del Maestro RF, Thaw HH, Bjork J et al (1980) Free radicals as mediators of tissue injury. Acta Physiol Scand 492:43–57

    Google Scholar 

  3. Simonini G, Pignone A, Generini S et al (2000) Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology 155:1–15

    Article  PubMed  CAS  Google Scholar 

  4. Murrell GAC, Francis MJO, Bromley L (1990) Modulation of fibroblasts proliferation by oxygen free radicals. Biochem J 265:659–665

    PubMed  CAS  Google Scholar 

  5. Simoni G, Cerinic MM, Generini S et al (1999) Oxidative stress in Systemic Sclerosis. Mol Cellular Biochem 196(1–2):85–91

    Article  Google Scholar 

  6. Cracowski JL, Marpeau C, Carpentier PH et al (2001) Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders. Arthritis Rheum 44(5):1143–1148

    Article  PubMed  CAS  Google Scholar 

  7. Stein CM, Tanner SB, Awad JA et al (1996) Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum 39(7):1146–1150

    PubMed  CAS  Google Scholar 

  8. Cracowski JL, Carpentier PH, Imbert B et al (2002) Increased urinary F2-isoprostanes in systemic sclerosis but not in primary Raynaud’s phenomenon: effect of cold exposure. Arthritis Rheum 46(5):1319–1323

    Article  PubMed  CAS  Google Scholar 

  9. Cantin AM, Hubbard RC, Crystal RG (1989) Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 139:370–372

    PubMed  CAS  Google Scholar 

  10. MacNee W, Rahman I (1995) Oxidants/antioxidants in idiopathic pulmonary fibrosis. Thorax 50:553–558

    Article  Google Scholar 

  11. Beeh KM, Beier J, Haas IC et al (2002) Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis. Eur Respir J 19:1119–1123

    Article  PubMed  CAS  Google Scholar 

  12. Behr J, Maier K, Krombach F et al (1991) Pathogenic significance of reactive oxygen species in diffuse fibrosing alveolitis. Am Rev Respir Dis 144:146–50

    PubMed  CAS  Google Scholar 

  13. Subcomittee for Scleroderma Criteria of The American Rheumatism Association Diagnostic, Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–586

    Google Scholar 

  14. Warrick JH, Bhalla M, Schabel AI, Silver RM (1991) High resolution computed tomography in early scleroderma lung disease. J Rheumatol 18:1520–1528

    PubMed  CAS  Google Scholar 

  15. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 12:302–310

    Google Scholar 

  16. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 126:131–138

    Article  PubMed  CAS  Google Scholar 

  17. Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500

    PubMed  CAS  Google Scholar 

  18. Sun L, Peterson TE, Mc Cormick ML, Oberley LW, Osborne JW (1989) Improved superoxide dismutase assay for clinical use. Clin Chem 35:1265–1266

    PubMed  CAS  Google Scholar 

  19. Yasmineh WG, Kaur TP, Blazar BR, Theologides A (1995) Serum catalase as marker of graft-versus-host disease in allogenic bone marrow transplant recipients. Clin Chem 41:1574–1580

    PubMed  CAS  Google Scholar 

  20. Quaife ML, Scrimshaw NS, Lowry OH (1949) A micromethod for assay of total tocopherols in blood serum. J Biol Chem 180:1229–1235

    CAS  PubMed  Google Scholar 

  21. Omage ST, Turnbull JD, Sauberlich HE (1979) Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol 6:3–13

    Google Scholar 

  22. Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A (2004) Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis. Am J Med 116(9):595–600

    Article  PubMed  CAS  Google Scholar 

  23. Fajoc I, Kahan A, Menkes CJ, Desanges JF, Dall J, Santucci A, Dinh-Xuan AT (1998) Increased NO in exhaled air in patients with SS. Clin Exp Rheumatol 16:547–552

    Google Scholar 

  24. Yamamato T, Katayama I, Nishioka K (1998) NO production and inducible NO synthase expression in SS. J Rheumatol 25:314–317

    Google Scholar 

  25. Herrick AL, Rieley F, Schofield, Hollis S, Braganza JM, Jayson MIV (1994) Micronutrient antioxidant status in patients with primary Raynaud’s phenomenon and systemic sclerosis. J Rheumatol 21:1477–1483

    PubMed  CAS  Google Scholar 

  26. Lundberg AC, Akesson A, Akesson B (1992) Dietary intake and nutritional status in patients with systemic sclerosis. Ann Rheumatol Dis 51:1143–1148

    Article  CAS  Google Scholar 

  27. Morita A, Minami H, Sakakibara N, Sato K, Tsuji TAD (1996) Elevated plasma superoxide dismutase activity in patients with systemic sclerosis. J Dermatol Sci 11:196–201

    Article  PubMed  CAS  Google Scholar 

  28. Denton CP, Bunce TD, Dorado MB, Roberts Z, Wilson H, Howell K, Bruckdorfer KR, Black CM (1999) Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud’s phenomenon. Rheumatology 38:309–315

    Article  PubMed  CAS  Google Scholar 

  29. Sambo P, Amico D, Giacomelli R, Matucci-Cerinic M, Salsano F, Valentini G, Gabrielli A (2001) Intravenous N-acetylcysteine for treatment of Reynaud’s phenomenon secondary to systemic sclerosis: a pilot study. J Rheumatol 28:2257–2262

    PubMed  CAS  Google Scholar 

  30. Failli P, Palmieri L, D’ Alfonso C, Giovannelli L, Generini S, Rosso AD, Pignone A, Stanflin N, Orsi S, Ziletti L, Matucci-Cerinic M (2002) Effect of N-acetyl-l-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis. Nitric Oxide 7:277–282

    Article  PubMed  CAS  Google Scholar 

  31. Clements PJ, Lachenbruch PA, Cheng S, Simmons M, Sterz M, Furst E (1990) Skin score A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 33:1256–1263

    Article  PubMed  CAS  Google Scholar 

  32. Steen VD, Medsger TA (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437–2444

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hande Ikitimur.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Musellim, B., Ikitimur, H., Uzun, H. et al. The oxidant–antioxidant balance in systemic sclerosis cases with interstitial lung involvement. Rheumatol Int 27, 163–167 (2006). https://doi.org/10.1007/s00296-006-0184-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-006-0184-6

Keywords

Navigation